Introduction Curatis AG is a Swiss-based specialty pharmaceutical company founded in 2002 by seasoned industry executives. As a privately owned entity, Curatis AG is dedicated to the acquisition, development, and commercialisation of innovative specialist medicines. The company's primary mission is to provide groundbreaking solutions for the prevention, diagnosis, and treatment of rare and specialty care diseases. With a commitment to innovation and excellence, Curatis AG is at the forefront of bringing life-changing therapies to patients in need. |